6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
1m ago	Amesite Announces Up To $6 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules
1m ago	Creator Platform Beats Global Field Two Years Running, as Social Content Evolves into Social Commerce
2m ago	American Rebel Holdings (NASDAQ: AREB) Announces Nasdaq Trading Resumption and Provides Shareholder Update
3m ago	Personalization at Scale: 3,000 Custom Baseballs, One Unforgettable Adobe Summit
3m ago	First Commerce Bancorp, Inc. Reports First Quarter 2026 Results and Declares a Cash Dividend

About

Artelo Biosciences Inc (NASDAQ:ARTL) — investor relations, events, news, and company updates on 6ix.

Latest News

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements

Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments

Financials

Revenue

$0

Market Cap

$5.32 M

EPS

-35.75

Community Chat

Ask AI